AKT1 and breast carcinoma: A study was published in 2009 on breast cancer cells by Srinivasan and coworkers where it was shown that diosgenin modulates AKT to regulate breast cancer cell survival and that this drug has no effect on normal breast epithelial cells (MCF-10A) except for its selective toxicity to cancer cells [108].